ANDA 62479, held by Ranbaxy. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62479 (Doxycycline Hyclate), held by Ranbaxy, was first approved by FDA on Dec 23, 1983, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 23, 1983 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 50MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Jun 1, 1993 | Supplement 15Labeling | Approved | None posted |
| Feb 19, 1993 | Supplement 14Labeling | Approved | None posted |
| Dec 23, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters